Infections with dengue virus have increased significantly over the past two decades and it is estimated that >3 billion people live in at-risk areas worldwide. Whitehead and colleagues discuss the challenges that are associated with the development of an effective tetravalent dengue vaccine and the progress that has been made towards achieving this goal.
- Stephen S. Whitehead
- Joseph E. Blaney
- Brian R. Murphy
